{"id":3390,"date":"2024-04-16T08:28:19","date_gmt":"2024-04-16T08:28:19","guid":{"rendered":"https:\/\/pharm.sinocurechem.com\/?p=3301"},"modified":"2024-04-16T08:28:19","modified_gmt":"2024-04-16T08:28:19","slug":"how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment","status":"publish","type":"post","link":"https:\/\/longchangextracts.com\/hu\/hogyan-forradalmasitja-a-protionamidok-attoro-mechanizmusa-a-tuberkulozis-kezeleset\/","title":{"rendered":"Hogyan forradalmas\u00edtja a Protionamid \u00e1tt\u00f6r\u0151 mechanizmusa a tuberkul\u00f3zis kezel\u00e9s\u00e9t!"},"content":{"rendered":"

1.\u00a0<\/span>\u00c1ttekint\u00e9s<\/span><\/b><\/b><\/p>\n

A protionamid, m\u00e1s n\u00e9ven protionamid egy szintetikus antibakteri\u00e1lis szer, amely a tioamid vegy\u00fcletek oszt\u00e1ly\u00e1ba tartozik.<\/span><\/p>\n

Els\u0151sorban a tuberkul\u00f3zis kezel\u00e9s\u00e9re haszn\u00e1lj\u00e1k, k\u00fcl\u00f6n\u00f6sen olyan esetekben, amikor a betegn\u00e9l rezisztencia alakult ki m\u00e1s els\u0151 vonalbeli tuberkul\u00f3zisellenes gy\u00f3gyszerekkel szemben.<\/span><\/p>\n

A protionamidot a multidrog-rezisztens tuberkul\u00f3zis (MDR-TB) \u00e9s a kiterjedten gy\u00f3gyszerrezisztens tuberkul\u00f3zis (XDR-TB) m\u00e1sodvonalbeli vagy alternat\u00edv kezel\u00e9si lehet\u0151s\u00e9gk\u00e9nt alkalmazz\u00e1k.<\/span><\/p>\n

2.\u00a0<\/span>K\u00e9miai szerkezet \u00e9s tulajdons\u00e1gok<\/span><\/b><\/b><\/p>\n

A.\u00a0<\/span>K\u00e9miai szerkezet<\/span><\/b><\/b><\/p>\n

A protionamid molekulaformul\u00e1ja C7H7N3S.<\/span><\/p>\n

A k\u00e9miai szerkezet egy tiazolgy\u0171r\u0171b\u0151l \u00e1ll (k\u00e9nt \u00e9s nitrog\u00e9nt tartalmaz\u00f3 \u00f6ttag\u00fa heterociklusos gy\u0171r\u0171), amelyhez egy aminocsoport \u00e9s egy karbonilcsoport kapcsol\u00f3dik.<\/span><\/p>\n

A tiazolgy\u0171r\u0171, a karbonilcsoport \u00e9s az aminocsoport a legfontosabb szerkezeti jellemz\u0151k, amelyek hozz\u00e1j\u00e1rulnak a vegy\u00fclet biol\u00f3giai aktivit\u00e1s\u00e1hoz \u00e9s fizikai-k\u00e9miai tulajdons\u00e1gaihoz.<\/span><\/p>\n

B.\u00a0<\/span>Fizikai \u00e9s k\u00e9miai tulajdons\u00e1gok<\/span><\/b><\/b><\/p>\n

Megjelen\u00e9s: feh\u00e9r vagy t\u00f6rtfeh\u00e9r krist\u00e1lyos por<\/span><\/p>\n

Molekulat\u00f6meg: 181,24 g\/mol<\/span><\/p>\n

Olvad\u00e1spont: 159-162\u00b0C<\/span><\/p>\n

Forr\u00e1spont: Nem j\u00f3l meghat\u00e1rozott (bomlik forr\u00e1s el\u0151tt)<\/span><\/p>\n

Oldhat\u00f3s\u00e1g: V\u00edzben, etanolban \u00e9s m\u00e1s pol\u00e1ros szerves old\u00f3szerekben old\u00f3dik.<\/span><\/p>\n

Enyh\u00e9n old\u00f3dik nem pol\u00e1ris old\u00f3szerekben, p\u00e9ld\u00e1ul \u00e9terben \u00e9s benzolban.<\/span><\/p>\n

Stabilit\u00e1s: F\u00e9nyre \u00e9s h\u0151re \u00e9rz\u00e9keny, ami leboml\u00e1shoz vezethet. A vizes oldatok hajlamosak lehetnek a hidrol\u00edzisre, k\u00fcl\u00f6n\u00f6sen savas vagy b\u00e1zikus k\u00f6r\u00fclm\u00e9nyek k\u00f6z\u00f6tt.<\/span><\/p>\n

Funkcion\u00e1lis csoportok:<\/span><\/p>\n

Tiazol gy\u0171r\u0171<\/span><\/p>\n

Karbonil (C=O) csoport<\/span><\/p>\n

Els\u0151dleges aminocsoport (NH2)<\/span><\/p>\n

Polarit\u00e1s \u00e9s t\u00f6lt\u00e9s:<\/span><\/p>\n

A protionamid a karbonil- \u00e9s aminocsoportok jelenl\u00e9te miatt pol\u00e1ros molekula.<\/span><\/p>\n

Fiziol\u00f3gi\u00e1s pH-n a vegy\u00fclet t\u00falnyom\u00f3r\u00e9szt semleges, nem ioniz\u00e1lt form\u00e1ban l\u00e9tezik.<\/span><\/p>\n

Spektroszk\u00f3piai tulajdons\u00e1gok:<\/span><\/p>\n

UV-Vis abszorpci\u00f3: A protionamid abszorpci\u00f3s maximuma 280-290 nm k\u00f6r\u00fcl van, ami kvantitat\u00edv elemz\u00e9sre haszn\u00e1lhat\u00f3.<\/span><\/p>\n

IR spektroszk\u00f3pia: Megfigyelhet\u0151k a karbonil-, amino- \u00e9s tiazolgy\u0171r\u0171re jellemz\u0151 abszorpci\u00f3s s\u00e1vok.<\/span><\/p>\n

NMR spektroszk\u00f3pia: Az 1H NMR- \u00e9s 13C NMR-spektrumok r\u00e9szletes inform\u00e1ci\u00f3t ny\u00fajtanak a vegy\u00fclet szerkezet\u00e9r\u0151l \u00e9s tisztas\u00e1g\u00e1r\u00f3l.<\/span><\/p>\n

3.\u00a0<\/span>A hat\u00e1smechanizmus<\/span><\/b><\/b><\/p>\n

A protionamid egy olyan prodrug, amely antibakteri\u00e1lis hat\u00e1sainak kifejt\u00e9s\u00e9hez a bakteri\u00e1lis EthA (Enoyl-[acil-hordoz\u00f3-protein] redukt\u00e1z) enzim aktiv\u00e1l\u00e1s\u00e1ra van sz\u00fcks\u00e9g.<\/span><\/p>\n

A protionamid aktiv\u00e1lt form\u00e1ja beavatkozik a mikolsavak szint\u00e9zis\u00e9be, amelyek a bakt\u00e9rium sejtfal\u00e1nak alapvet\u0151 \u00f6sszetev\u0151i.<\/span><\/p>\n

A sejtfal integrit\u00e1s\u00e1nak ez a s\u00e9r\u00fcl\u00e9se a bakt\u00e9riumok n\u00f6veked\u00e9s\u00e9nek g\u00e1tl\u00e1s\u00e1hoz \u00e9s v\u00e9g\u00fcl a sejtek elhal\u00e1s\u00e1hoz vezet.<\/span><\/p>\n

4.\u00a0<\/span>Prodrug aktiv\u00e1l\u00e1s<\/span><\/b><\/b><\/p>\n

A protionamid egy prodrug, ami azt jelenti, hogy antibakteri\u00e1lis hat\u00e1sainak kifejt\u00e9s\u00e9hez metabolikus aktiv\u00e1l\u00e1sra van sz\u00fcks\u00e9g.<\/span><\/p>\n

Az aktiv\u00e1l\u00e1si folyamat a protionamid enzimatikus \u00e1talak\u00edt\u00e1s\u00e1t foglalja mag\u00e1ban egy EthA (Enoyl-[acyl-carrier-protein] redukt\u00e1z) nev\u0171 mikobakteri\u00e1lis enzim \u00e1ltal.<\/span><\/p>\n

Az EthA egy flavin-adenin-dinukleotid (FAD)-f\u00fcgg\u0151 monooxigen\u00e1z enzim, amely kataliz\u00e1lja a protionamid oxidat\u00edv aktiv\u00e1l\u00e1s\u00e1t.<\/span><\/p>\n

A.\u00a0<\/span>A hat\u00e1smechanizmus<\/span><\/b><\/b><\/p>\n

1.\u00a0<\/span>EthA-medi\u00e1lt aktiv\u00e1l\u00e1s:<\/span><\/p>\n

A Mycobacterium tuberculosisban \u00e9s m\u00e1s mikobakt\u00e9riumokban az EthA enzim felel\u0151s a protionamid aktiv\u00e1l\u00e1s\u00e1\u00e9rt.<\/span><\/p>\n

Az EthA kataliz\u00e1lja a protionamid tioamid csoportj\u00e1nak oxid\u00e1ci\u00f3j\u00e1t, \u00e9s egy reakt\u00edv intermedierr\u00e9 alak\u00edtja \u00e1t.<\/span><\/p>\n

A protionamidnak ez az aktiv\u00e1lt form\u00e1ja a felt\u00e9telez\u00e9sek szerint az els\u0151dleges antibakteri\u00e1lis szer, amely kifejti hat\u00e1s\u00e1t a mikobakt\u00e9riumsejtekre.<\/span><\/p>\n

2.\u00a0<\/span>A mikolsavszint\u00e9zis g\u00e1tl\u00e1sa:<\/span><\/p>\n

A protionamid aktiv\u00e1lt form\u00e1ja beavatkozik a mikolsavak szint\u00e9zis\u00e9be, amelyek a mikobakt\u00e9riumok sejtfal\u00e1nak alapvet\u0151 \u00f6sszetev\u0151i.<\/span><\/p>\n

A mikolsavak hossz\u00fa l\u00e1nc\u00fa, el\u00e1gaz\u00f3 l\u00e1nc\u00fa zs\u00edrsavak, amelyek kritikus fontoss\u00e1g\u00faak a mikobakt\u00e9rium sejtfal\u00e1nak szerkezeti integrit\u00e1sa \u00e9s \u00e1tereszt\u0151k\u00e9pess\u00e9ge szempontj\u00e1b\u00f3l.<\/span><\/p>\n

Ezen l\u00e9tfontoss\u00e1g\u00fa sejtfal-\u00f6sszetev\u0151k szint\u00e9zis\u00e9nek megzavar\u00e1s\u00e1val a protionamid vesz\u00e9lyezteti a mikobakt\u00e9rium sejtfal\u00e1nak integrit\u00e1s\u00e1t, ami sejthal\u00e1lhoz vagy n\u00f6veked\u00e9sg\u00e1tl\u00e1shoz vezet.<\/span><\/p>\n

3.\u00a0<\/span>A sejtek anyagcser\u00e9j\u00e9nek megv\u00e1ltoz\u00e1sa:<\/span><\/p>\n

A mikolsavszint\u00e9zisre gyakorolt k\u00f6zvetlen hat\u00e1s\u00e1n k\u00edv\u00fcl a protionamid aktiv\u00e1lt form\u00e1ja a mikobakt\u00e9riumok m\u00e1s sejtfolyamataiba is beavatkozhat.<\/span><\/p>\n

Felt\u00e9telez\u00e9sek szerint a protionamid befoly\u00e1solhatja a lipidanyagcser\u00e9ben, az energiatermel\u00e9sben \u00e9s m\u00e1s alapvet\u0151 sejtfunkci\u00f3kban r\u00e9szt vev\u0151 k\u00fcl\u00f6nb\u00f6z\u0151 enzimek expresszi\u00f3j\u00e1t vagy aktivit\u00e1s\u00e1t.<\/span><\/p>\n

Ezek a sejtanyagcser\u00e9re gyakorolt k\u00f6zvetett hat\u00e1sok tov\u00e1bb j\u00e1rulhatnak hozz\u00e1 a protionamid antimikobakteri\u00e1lis hat\u00e1s\u00e1hoz.<\/span><\/p>\n

B.\u00a0<\/span>Specifikuss\u00e1g \u00e9s ellen\u00e1ll\u00f3k\u00e9pess\u00e9g<\/span><\/b><\/b><\/p>\n

A protionamid hat\u00e1smechanizmusa els\u0151sorban a mikobakt\u00e9riumokra, k\u00fcl\u00f6n\u00f6sen a Mycobacterium tuberculosisra, a tuberkul\u00f3zis k\u00f3rokoz\u00f3j\u00e1ra ir\u00e1nyul.<\/span><\/p>\n

Az EthA \u00e1ltal k\u00f6zvet\u00edtett aktiv\u00e1l\u00e1si folyamat a hat\u00e1smechanizmus d\u00f6nt\u0151 l\u00e9p\u00e9se, \u00e9s az EthA enzim mut\u00e1ci\u00f3i vagy v\u00e1ltoz\u00e1sai a protionamiddal szembeni rezisztenci\u00e1hoz vezethetnek.<\/span><\/p>\n

A rezisztencia mechanizmusainak, p\u00e9ld\u00e1ul az EthA g\u00e9n mut\u00e1ci\u00f3inak meg\u00e9rt\u00e9se fontos a Protionamid gy\u00f3gyszerrezisztens tuberkul\u00f3zis kezel\u00e9s\u00e9ben val\u00f3 alkalmaz\u00e1s\u00e1nak optimaliz\u00e1l\u00e1s\u00e1hoz.<\/span><\/p>\n

\u00d6sszess\u00e9g\u00e9ben a protionamid r\u00e9szletes hat\u00e1smechanizmusa a prodrug EthA-medi\u00e1lt aktiv\u00e1l\u00e1s\u00e1t foglalja mag\u00e1ban, amelyet a mikolsavszint\u00e9zis \u00e9s potenci\u00e1lisan m\u00e1s sejtfolyamatok megzavar\u00e1sa k\u00f6vet, ami v\u00e9g\u00fcl a mikobakt\u00e9riumok n\u00f6veked\u00e9s\u00e9nek \u00e9s a sejthal\u00e1lnak a g\u00e1tl\u00e1s\u00e1hoz vezet.<\/span><\/p>\n

5.\u00a0<\/span>Ter\u00e1pi\u00e1s alkalmaz\u00e1sok:<\/span><\/b><\/b><\/p>\n

A Protionamidot els\u0151sorban a tuberkul\u00f3zis kezel\u00e9s\u00e9re haszn\u00e1lj\u00e1k, k\u00fcl\u00f6n\u00f6sen olyan esetekben, amikor a betegn\u00e9l rezisztencia alakult ki m\u00e1s els\u0151 vonalbeli tuberkul\u00f3zisellenes gy\u00f3gyszerekkel, p\u00e9ld\u00e1ul az izoniaziddal \u00e9s a rifampicinnel szemben.<\/span><\/p>\n

Gyakran alkalmazz\u00e1k m\u00e1s tuberkul\u00f3zisellenes szerekkel, p\u00e9ld\u00e1ul pirazinamiddal, etambutollal \u00e9s fluorokinolonokkal kombin\u00e1lva, hogy fokozz\u00e1k a kezel\u00e9si s\u00e9ma hat\u00e9konys\u00e1g\u00e1t.<\/span><\/p>\n

A protionamidot a m\u00e1sik mikobakteri\u00e1lis fert\u0151z\u00e9s, a lepra kezel\u00e9s\u00e9re is lehet haszn\u00e1lni, olyan esetekben, amikor a beteg rezisztenci\u00e1t fejlesztett ki a szok\u00e1sos lepra kezel\u00e9sekkel szemben.<\/span><\/p>\n

A.\u00a0<\/span>A tuberkul\u00f3zis kezel\u00e9se<\/span><\/b><\/b><\/p>\n

A Protionamid els\u0151dleges \u00e9s legelterjedtebb felhaszn\u00e1l\u00e1si ter\u00fclete a tuberkul\u00f3zis (TBC) kezel\u00e9se, k\u00fcl\u00f6n\u00f6sen olyan esetekben, amikor a betegn\u00e9l rezisztencia alakult ki m\u00e1s els\u0151 vonalbeli tuberkul\u00f3zisellenes gy\u00f3gyszerekkel szemben.<\/span><\/p>\n

A protionamidot \u00e1ltal\u00e1ban m\u00e1sodvonalbeli vagy alternat\u00edv kezel\u00e9si lehet\u0151s\u00e9gk\u00e9nt alkalmazz\u00e1k a multidrog-rezisztens tuberkul\u00f3zis (MDR-TB) \u00e9s a kiterjedten gy\u00f3gyszerrezisztens tuberkul\u00f3zis (XDR-TB) kezel\u00e9s\u00e9re.<\/span><\/p>\n

Ezekben az esetekben a Protionamidot \u00e1ltal\u00e1ban m\u00e1s tuberkul\u00f3zisellenes szerekkel, p\u00e9ld\u00e1ul pirazinamiddal, etambutollal \u00e9s fluorokinolonokkal kombin\u00e1lva alkalmazz\u00e1k, hogy hat\u00e9konyabb \u00e9s \u00e1tfog\u00f3bb kezel\u00e9si s\u00e9m\u00e1t hozzanak l\u00e9tre.<\/span><\/p>\n

B.\u00a0<\/span>Haszn\u00e1lat a multidrog-rezisztens tuberkul\u00f3zisban (MDR-TB):<\/span><\/b><\/b><\/p>\n

Az MDR-TB a tuberkul\u00f3zis olyan form\u00e1ja, amely rezisztens a leger\u0151sebb els\u0151 vonalbeli tuberkul\u00f3zisellenes gy\u00f3gyszerek k\u00f6z\u00fcl legal\u00e1bb kett\u0151vel, az izoniaziddal \u00e9s a rifampicinnel szemben.<\/span><\/p>\n

A protionamid hat\u00e1sosnak bizonyult az MDR-TB kezel\u00e9s\u00e9ben, k\u00fcl\u00f6n\u00f6sen azokban az esetekben, amikor a beteg nem reag\u00e1lt m\u00e1s m\u00e1sodvonalbeli tuberkul\u00f3zisellenes gy\u00f3gyszerekre vagy nem toler\u00e1lta azokat.<\/span><\/p>\n

A protionamid be\u00e9p\u00edt\u00e9se az MDR-TB kezel\u00e9si rendj\u00e9be jav\u00edthatja a kezel\u00e9s eredm\u00e9nyeit \u00e9s n\u00f6velheti a betegs\u00e9g sikeres kezel\u00e9s\u00e9nek es\u00e9ly\u00e9t.<\/span><\/p>\n

C.\u00a0<\/span>A kiterjedten gy\u00f3gyszerrezisztens tuberkul\u00f3zis (XDR-TB) kezel\u00e9se:<\/span><\/b><\/b><\/p>\n

Az XDR-TB a gy\u00f3gyszerrezisztens tuberkul\u00f3zis m\u00e9g s\u00falyosabb form\u00e1ja, amikor a t\u00f6rzs rezisztens az izoniazidra \u00e9s a rifampicinre, valamint b\u00e1rmely fluorokinolonra \u00e9s a h\u00e1rom injekt\u00e1lhat\u00f3 m\u00e1sodvonalbeli gy\u00f3gyszer (amikacin, kanamicin vagy kapreomicin) k\u00f6z\u00fcl legal\u00e1bb egyre.<\/span><\/p>\n

A protionamidot az XDR-TB kezel\u00e9s\u00e9nek kritikus komponensek\u00e9nt ismerik el, mivel hat\u00e9konyabb \u00e9s szem\u00e9lyre szabott kezel\u00e9si s\u00e9m\u00e1k kialak\u00edt\u00e1s\u00e1ra haszn\u00e1lhat\u00f3 ezekben a nehezen kezelhet\u0151 esetekben.<\/span><\/p>\n

Az Eg\u00e9szs\u00e9g\u00fcgyi Vil\u00e1gszervezet (WHO) a Protionamidot felvette az XDR-TB kezel\u00e9s\u00e9re vonatkoz\u00f3 aj\u00e1nl\u00e1sai k\u00f6z\u00e9, kiemelve annak fontoss\u00e1g\u00e1t e glob\u00e1lis k\u00f6zeg\u00e9szs\u00e9g\u00fcgyi kih\u00edv\u00e1s kezel\u00e9s\u00e9ben.<\/span><\/p>\n

D.\u00a0<\/span>A lepra kezel\u00e9se:<\/span><\/b><\/b><\/p>\n

B\u00e1r kev\u00e9sb\u00e9 gyakori, a protionamidot a Mycobacterium leprae \u00e1ltal okozott m\u00e1sik mikobakteri\u00e1lis fert\u0151z\u00e9s, a lepra kezel\u00e9s\u00e9re is alkalmazt\u00e1k.<\/span><\/p>\n

Bizonyos esetekben, k\u00fcl\u00f6n\u00f6sen, ha a betegn\u00e9l rezisztencia alakult ki a szok\u00e1sos lepra kezel\u00e9sekkel szemben, a Protionamid alternat\u00edv vagy kieg\u00e9sz\u00edt\u0151 ter\u00e1pi\u00e1s lehet\u0151s\u00e9gk\u00e9nt alkalmazhat\u00f3.<\/span><\/p>\n

A protionamid alkalmaz\u00e1sa lepr\u00e1ban \u00e1ltal\u00e1ban korl\u00e1tozott, \u00e9s a beteg k\u00f3rt\u00f6rt\u00e9net\u00e9nek, valamint a fert\u0151z\u0151 t\u00f6rzs specifikus rezisztenciamint\u00e1inak gondos m\u00e9rlegel\u00e9s\u00e9t ig\u00e9nyli.<\/span><\/p>\n

E.\u00a0<\/span>Adagol\u00e1s \u00e9s alkalmaz\u00e1s:<\/span><\/b><\/b><\/p>\n

A protionamidot \u00e1ltal\u00e1ban sz\u00e1jon \u00e1t adj\u00e1k be, \u00e9s az adagot a beteg s\u00falya, \u00e9letkora \u00e9s a konkr\u00e9t kezel\u00e9si rend alapj\u00e1n hat\u00e1rozz\u00e1k meg.<\/span><\/p>\n

A Protionamid aj\u00e1nlott adagja v\u00e1ltozhat, de gyakran m\u00e1s tuberkul\u00f3zis- vagy lepraellenes gy\u00f3gyszerekkel egy\u00fctt \u00edrj\u00e1k fel.<\/span><\/p>\n

A Protionamid-kezel\u00e9s sor\u00e1n elengedhetetlen a beteg kezel\u00e9sre adott v\u00e1lasz\u00e1nak, valamint a mell\u00e9khat\u00e1soknak a megfelel\u0151 nyomon k\u00f6vet\u00e9se.<\/span><\/p>\n

F.\u00a0<\/span>Hat\u00f3s\u00e1gi j\u00f3v\u00e1hagy\u00e1sok \u00e9s ir\u00e1nymutat\u00e1sok:<\/span><\/b><\/b><\/p>\n

A protionamidot t\u00f6bb orsz\u00e1gban, k\u00f6zt\u00fck Indi\u00e1ban, Oroszorsz\u00e1gban \u00e9s n\u00e9h\u00e1ny eur\u00f3pai orsz\u00e1gban enged\u00e9lyezt\u00e9k a tuberkul\u00f3zis kezel\u00e9s\u00e9re.<\/span><\/p>\n

Az Eg\u00e9szs\u00e9g\u00fcgyi Vil\u00e1gszervezet (WHO) felvette a protionamidot az MDR-TB \u00e9s XDR-TB kezel\u00e9s\u00e9re szolg\u00e1l\u00f3 alapvet\u0151 gy\u00f3gyszerek list\u00e1j\u00e1ra, elismerve annak fontoss\u00e1g\u00e1t a gy\u00f3gyszerrezisztens tuberkul\u00f3zis kezel\u00e9s\u00e9ben.<\/span><\/p>\n

A nemzeti \u00e9s nemzetk\u00f6zi ir\u00e1nyelvek, p\u00e9ld\u00e1ul a WHO \u00e9s a nemzeti TBC-ellen\u0151rz\u00e9si programok aj\u00e1nl\u00e1sai a protionamidnak a k\u00fcl\u00f6nb\u00f6z\u0151 tuberkul\u00f3zis-kezel\u00e9si s\u00e9m\u00e1kban val\u00f3 alkalmaz\u00e1s\u00e1ra vonatkoznak.<\/span><\/p>\n

6.\u00a0<\/span>Farmakokinetika \u00e9s adagol\u00e1s:<\/span><\/b><\/b><\/p>\n

A protionamidot \u00e1ltal\u00e1ban sz\u00e1jon \u00e1t adj\u00e1k be, az aj\u00e1nlott adagol\u00e1s a konkr\u00e9t kezel\u00e9si s\u00e9m\u00e1t\u00f3l, valamint a beteg s\u00faly\u00e1t\u00f3l \u00e9s \u00e9letkor\u00e1t\u00f3l f\u00fcgg.<\/span><\/p>\n

A gy\u00f3gyszer j\u00f3l felsz\u00edv\u00f3dik a gyomor-b\u00e9l traktusb\u00f3l, a plazma cs\u00facskoncentr\u00e1ci\u00f3j\u00e1t a sz\u00e1jon \u00e1t t\u00f6rt\u00e9n\u0151 bead\u00e1st k\u00f6vet\u0151 1-2 \u00f3r\u00e1n bel\u00fcl \u00e9ri el.<\/span><\/p>\n

A protionamid els\u0151sorban a m\u00e1jban metaboliz\u00e1l\u00f3dik \u00e9s a ves\u00e9n kereszt\u00fcl \u00fcr\u00fcl, felez\u00e9si ideje k\u00f6r\u00fclbel\u00fcl 2-3 \u00f3ra.<\/span><\/p>\n

A.\u00a0<\/span>Farmakokinetika<\/span><\/b><\/b><\/p>\n

a.\u00a0<\/span>Abszorpci\u00f3<\/span><\/b><\/b><\/p>\n

A protionamidot \u00e1ltal\u00e1ban sz\u00e1jon \u00e1t adj\u00e1k be, \u00e9s j\u00f3l felsz\u00edv\u00f3dik a gyomor-b\u00e9lrendszerb\u0151l.<\/span><\/p>\n

Or\u00e1lis bead\u00e1st k\u00f6vet\u0151en a plazma cs\u00facskoncentr\u00e1ci\u00f3ja jellemz\u0151en 1-2 \u00f3r\u00e1n bel\u00fcl alakul ki, ami viszonylag gyors felsz\u00edv\u00f3d\u00e1sra utal.<\/span><\/p>\n

A protionamid or\u00e1lis biohasznosul\u00e1sa a jelent\u00e9sek szerint 60-80% k\u00f6z\u00f6tt van, ami j\u00f3 b\u00e9lrendszeri felsz\u00edv\u00f3d\u00e1sra utal.<\/span><\/p>\n

b.\u00a0<\/span>Forgalmaz\u00e1s<\/span><\/b><\/b><\/p>\n

A felsz\u00edv\u00f3d\u00e1s ut\u00e1n a protionamid sz\u00e9les k\u00f6rben eloszlik a szervezetben.<\/span><\/p>\n

K\u00e9pes behatolni a k\u00fcl\u00f6nb\u00f6z\u0151 sz\u00f6vetekbe \u00e9s szervekbe, bele\u00e9rtve a t\u00fcd\u0151t is, ahol magas koncentr\u00e1ci\u00f3t \u00e9rhet el.<\/span><\/p>\n

A protionamidr\u00f3l ismert, hogy \u00e1tjut a v\u00e9r-agy g\u00e1ton, \u00edgy eljut a k\u00f6zponti idegrendszerbe.<\/span><\/p>\n

A protionamid eloszl\u00e1si t\u00e9rfogata a becsl\u00e9sek szerint 1-2 L\/kg k\u00f6r\u00fcl van, ami viszonylag kiterjedt eloszl\u00e1st jelez.<\/span><\/p>\n

c.\u00a0<\/span>Anyagcsere \u00e9s kiv\u00e1laszt\u00e1s<\/span><\/b><\/b><\/p>\n

A protionamid els\u0151sorban a m\u00e1jban metaboliz\u00e1l\u00f3dik, ahol k\u00fcl\u00f6nb\u00f6z\u0151 biotranszform\u00e1ci\u00f3s reakci\u00f3kon megy kereszt\u00fcl.<\/span><\/p>\n

A f\u0151 metabolikus \u00fatvonal a protionamid oxidat\u00edv deamin\u00e1l\u00e1s\u00e1t foglalja mag\u00e1ban az EthA enzim \u00e1ltal, amely ugyanaz az enzim, amely a prodrug aktiv\u00e1l\u00e1s\u00e1\u00e9rt felel\u0151s.<\/span><\/p>\n

M\u00e1s metabolikus \u00fatvonalak is r\u00e9szt vehetnek, bele\u00e9rtve a konjug\u00e1ci\u00f3s reakci\u00f3kat \u00e9s tov\u00e1bbi oxid\u00e1ci\u00f3s l\u00e9p\u00e9seket.<\/span><\/p>\n

A protionamid metabolitjai t\u00falnyom\u00f3r\u00e9szt a ves\u00e9n kereszt\u00fcl elimin\u00e1l\u00f3dnak, a bejelentett felez\u00e9si id\u0151 k\u00f6r\u00fclbel\u00fcl 2-3 \u00f3ra.<\/span><\/p>\n

B.\u00a0<\/span>Adagol\u00e1s \u00e9s alkalmaz\u00e1s<\/span><\/b><\/b><\/p>\n

a.\u00a0<\/span>Aj\u00e1nlott adagol\u00e1s<\/span><\/b><\/b><\/p>\n

A Protionamid aj\u00e1nlott adagja a tuberkul\u00f3zis kezel\u00e9s\u00e9re a konkr\u00e9t kezel\u00e9si s\u00e9m\u00e1t\u00f3l \u00e9s a beteg jellemz\u0151it\u0151l f\u00fcgg\u0151en v\u00e1ltozik.<\/span><\/p>\n

A tipikus feln\u0151tt adagok napi 0,5 \u00e9s 1 gramm k\u00f6z\u00f6tt mozognak, \u00e1ltal\u00e1ban k\u00e9t vagy h\u00e1rom adagra elosztva.<\/span><\/p>\n

Az adagol\u00e1s a beteg tests\u00falya, \u00e9letkora \u00e9s a kezel\u00e9sre adott klinikai v\u00e1lasz alapj\u00e1n m\u00f3dos\u00edthat\u00f3.<\/span><\/p>\n

b.\u00a0<\/span>Adagol\u00e1si be\u00e1ll\u00edt\u00e1sok<\/span><\/b><\/b><\/p>\n

Gyeng\u00fclt m\u00e1j- vagy vesefunkci\u00f3j\u00fa betegekn\u00e9l a Protionamid adagj\u00e1t cs\u00f6kkenteni kell a fokozott mell\u00e9khat\u00e1sok kock\u00e1zat\u00e1nak elker\u00fcl\u00e9se \u00e9rdek\u00e9ben.<\/span><\/p>\n

A Protionamid-kezel\u00e9s sor\u00e1n a m\u00e1j- \u00e9s a vesefunkci\u00f3 gondos ellen\u0151rz\u00e9se sz\u00fcks\u00e9ges, \u00e9s az adagot ennek megfelel\u0151en lehet m\u00f3dos\u00edtani.<\/span><\/p>\n

S\u00falyos mell\u00e9khat\u00e1sok vagy intolerancia eset\u00e9n a Protionamid adagj\u00e1t \u00e1tmenetileg cs\u00f6kkenteni kell, vagy a kezel\u00e9st \u00e1tmenetileg meg kell szak\u00edtani.<\/span><\/p>\n

c.\u00a0<\/span>Adminisztr\u00e1ci\u00f3<\/span><\/b><\/b><\/p>\n

A protionamidot \u00e1ltal\u00e1ban sz\u00e1jon \u00e1t, \u00e9tellel vagy an\u00e9lk\u00fcl adj\u00e1k be.<\/span><\/p>\n

Fontos, hogy tartsa be az el\u0151\u00edrt adagol\u00e1si \u00fctemtervet, \u00e9s ne hagyja ki vagy hagyja ki az adagokat, mivel ez befoly\u00e1solhatja a kezel\u00e9s \u00e1ltal\u00e1nos hat\u00e9konys\u00e1g\u00e1t.<\/span><\/p>\n

Bizonyos esetekben a Protionamid m\u00e1s tuberkul\u00f3zis- vagy lepraellenes gy\u00f3gyszerekkel kombin\u00e1lva alkalmazhat\u00f3, a konkr\u00e9t adagol\u00e1si \u00e9s alkalmaz\u00e1si rendet az adott beteg ig\u00e9nyeihez igaz\u00edtva.<\/span><\/p>\n

d.\u00a0<\/span>Farmakokinetikai megfontol\u00e1sok<\/span><\/b><\/b><\/p>\n

A protionamid viszonylag r\u00f6vid felez\u00e9si ideje (2-3 \u00f3ra) sz\u00fcks\u00e9gess\u00e9 teheti a napi t\u00f6bbsz\u00f6ri adagol\u00e1st a ter\u00e1pi\u00e1s gy\u00f3gyszerszint fenntart\u00e1s\u00e1hoz.<\/span><\/p>\n

Az olyan t\u00e9nyez\u0151k, mint az \u00e9lelmiszer-bevitel, az egyidej\u0171leg alkalmazott gy\u00f3gyszerek \u00e9s az egy\u00e9ni betegjellemz\u0151k befoly\u00e1solhatj\u00e1k a Protionamid farmakokinetik\u00e1j\u00e1t, \u00e9s sz\u00fcks\u00e9gess\u00e9 tehetik az adag m\u00f3dos\u00edt\u00e1s\u00e1t.<\/span><\/p>\n

A ter\u00e1pi\u00e1s gy\u00f3gyszeres megfigyel\u00e9s bizonyos esetekben hasznos lehet annak biztos\u00edt\u00e1sa \u00e9rdek\u00e9ben, hogy a beteg Protionamid-szintje a k\u00edv\u00e1nt ter\u00e1pi\u00e1s tartom\u00e1nyon bel\u00fcl legyen.<\/span><\/p>\n

7.\u00a0<\/span>Nemk\u00edv\u00e1natos hat\u00e1sok \u00e9s \u00f3vint\u00e9zked\u00e9sek<\/span><\/b><\/b><\/p>\n

A Protionamiddal kapcsolatos gyakori mell\u00e9khat\u00e1sok k\u00f6z\u00e9 tartozik a h\u00e1nyinger, h\u00e1ny\u00e1s, hasi f\u00e1jdalom \u00e9s hepatotoxicit\u00e1s (m\u00e1jtoxicit\u00e1s).<\/span><\/p>\n

A Protionamid-kezel\u00e9s sor\u00e1n a m\u00e1jm\u0171k\u00f6d\u00e9s gondos ellen\u0151rz\u00e9se sz\u00fcks\u00e9ges, \u00e9s s\u00falyos m\u00e1jk\u00e1rosod\u00e1s eset\u00e9n az adagot m\u00f3dos\u00edtani kell, vagy a kezel\u00e9st abba kell hagyni.<\/span><\/p>\n

A m\u00e1r megl\u00e9v\u0151 m\u00e1j- vagy vesebetegs\u00e9gben szenved\u0151 betegekn\u00e9l nagyobb lehet a mell\u00e9khat\u00e1sok kock\u00e1zata, \u00e9s szorosabb megfigyel\u00e9st ig\u00e9nyelhetnek.<\/span><\/p>\n

8.\u00a0<\/span>Szab\u00e1lyoz\u00e1si st\u00e1tusz \u00e9s klinikai vizsg\u00e1latok<\/span><\/b><\/b><\/p>\n

A protionamidot t\u00f6bb orsz\u00e1gban, k\u00f6zt\u00fck Indi\u00e1ban, Oroszorsz\u00e1gban \u00e9s n\u00e9h\u00e1ny eur\u00f3pai orsz\u00e1gban enged\u00e9lyezt\u00e9k a tuberkul\u00f3zis kezel\u00e9s\u00e9re.<\/span><\/p>\n

Az Eg\u00e9szs\u00e9g\u00fcgyi Vil\u00e1gszervezet az MDR-TB \u00e9s az XDR-TB kezel\u00e9s\u00e9re szolg\u00e1l\u00f3 alapvet\u0151 gy\u00f3gyszerek list\u00e1j\u00e1n szerepel.<\/span><\/p>\n

A folyamatban l\u00e9v\u0151 klinikai kutat\u00e1sok a Protionamid k\u00fcl\u00f6nb\u00f6z\u0151 kezel\u00e9si s\u00e9m\u00e1kban val\u00f3 alkalmaz\u00e1s\u00e1t, valamint \u00faj formul\u00e1k kifejleszt\u00e9s\u00e9t vizsg\u00e1lj\u00e1k a toler\u00e1lhat\u00f3s\u00e1g \u00e9s a hat\u00e9konys\u00e1g jav\u00edt\u00e1sa \u00e9rdek\u00e9ben.<\/span><\/p>\n

9.\u00a0<\/span>Gy\u00e1rt\u00e1s \u00e9s ell\u00e1t\u00e1s<\/span><\/b><\/b><\/p>\n

A protionamidot jellemz\u0151en k\u00e9miai szint\u00e9zisfolyamatok r\u00e9v\u00e9n \u00e1ll\u00edtj\u00e1k el\u0151, amelyek sor\u00e1n a 2-amino-tiazolt k\u00fcl\u00f6nb\u00f6z\u0151 reagensekkel reag\u00e1ltatj\u00e1k.<\/span><\/p>\n

A Protionamid gy\u00e1rt\u00e1sa \u00e9s sz\u00e1ll\u00edt\u00e1sa bizonyos gy\u00f3gyszeripari v\u00e1llalatokra vagy kutat\u00f3int\u00e9zetekre korl\u00e1toz\u00f3dhat, amelyek rendelkeznek a sz\u00fcks\u00e9ges gy\u00e1rt\u00e1si k\u00e9pess\u00e9gekkel \u00e9s hat\u00f3s\u00e1gi enged\u00e9lyekkel.<\/span><\/p>\n

A Protionamidhoz val\u00f3 hozz\u00e1f\u00e9r\u00e9s az adott orsz\u00e1gt\u00f3l vagy r\u00e9gi\u00f3t\u00f3l f\u00fcgg\u0151en v\u00e1ltozhat, mivel a k\u00fcl\u00f6nb\u00f6z\u0151 piacokon a rendelkez\u00e9sre \u00e1ll\u00e1st\u00f3l \u00e9s a forgalmaz\u00e1si csatorn\u00e1kt\u00f3l f\u00fcgg.<\/span><\/p>","protected":false},"excerpt":{"rendered":"

1.\u00a0Overview Protionamide, also known as Prothionamide, is a synthetic antibacterial agent that belongs to the thioamide class of compounds. It is primarily used in the treatment of tuberculosis, particularly in cases where the patient has developed resistance to other first-line anti-tuberculosis drugs. Protionamide has been used as a second-line or alternative treatment option for multidrug-resistant […]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"yoast_head":"\nHow Protionamide's Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment! - China Chemical Manufacturer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/longchangextracts.com\/hu\/hogyan-forradalmasitja-a-protionamidok-attoro-mechanizmusa-a-tuberkulozis-kezeleset\/\" \/>\n<meta property=\"og:locale\" content=\"hu_HU\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How Protionamide's Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment! - China Chemical Manufacturer\" \/>\n<meta property=\"og:description\" content=\"1.\u00a0Overview Protionamide, also known as Prothionamide, is a synthetic antibacterial agent that belongs to the thioamide class of compounds. It is primarily used in the treatment of tuberculosis, particularly in cases where the patient has developed resistance to other first-line anti-tuberculosis drugs. Protionamide has been used as a second-line or alternative treatment option for multidrug-resistant […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/longchangextracts.com\/hu\/hogyan-forradalmasitja-a-protionamidok-attoro-mechanizmusa-a-tuberkulozis-kezeleset\/\" \/>\n<meta property=\"og:site_name\" content=\"China Chemical Manufacturer\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-16T08:28:19+00:00\" \/>\n<meta name=\"author\" content=\"longcha9\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Szerz\u0151:\" \/>\n\t<meta name=\"twitter:data1\" content=\"longcha9\" \/>\n\t<meta name=\"twitter:label2\" content=\"Becs\u00fclt olvas\u00e1si id\u0151\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 perc\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/\",\"url\":\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/\",\"name\":\"How Protionamide's Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment! - China Chemical Manufacturer\",\"isPartOf\":{\"@id\":\"https:\/\/longchangextracts.com\/#website\"},\"datePublished\":\"2024-04-16T08:28:19+00:00\",\"dateModified\":\"2024-04-16T08:28:19+00:00\",\"author\":{\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869\"},\"breadcrumb\":{\"@id\":\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/#breadcrumb\"},\"inLanguage\":\"hu\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/longchangextracts.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How Protionamide’s Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/longchangextracts.com\/#website\",\"url\":\"https:\/\/longchangextracts.com\/\",\"name\":\"China Chemical Manufacturer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/longchangextracts.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"hu\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869\",\"name\":\"longcha9\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hu\",\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g\",\"caption\":\"longcha9\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hogyan forradalmas\u00edtja a Protionamid \u00e1tt\u00f6r\u0151 mechanizmusa a tuberkul\u00f3zis kezel\u00e9s\u00e9t! - K\u00edna Vegyi Gy\u00e1rt\u00f3","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/longchangextracts.com\/hu\/hogyan-forradalmasitja-a-protionamidok-attoro-mechanizmusa-a-tuberkulozis-kezeleset\/","og_locale":"hu_HU","og_type":"article","og_title":"How Protionamide's Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment! - China Chemical Manufacturer","og_description":"1.\u00a0Overview Protionamide, also known as Prothionamide, is a synthetic antibacterial agent that belongs to the thioamide class of compounds. It is primarily used in the treatment of tuberculosis, particularly in cases where the patient has developed resistance to other first-line anti-tuberculosis drugs. Protionamide has been used as a second-line or alternative treatment option for multidrug-resistant […]","og_url":"https:\/\/longchangextracts.com\/hu\/hogyan-forradalmasitja-a-protionamidok-attoro-mechanizmusa-a-tuberkulozis-kezeleset\/","og_site_name":"China Chemical Manufacturer","article_published_time":"2024-04-16T08:28:19+00:00","author":"longcha9","twitter_card":"summary_large_image","twitter_misc":{"Szerz\u0151:":"longcha9","Becs\u00fclt olvas\u00e1si id\u0151":"9 perc"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/","url":"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/","name":"Hogyan forradalmas\u00edtja a Protionamid \u00e1tt\u00f6r\u0151 mechanizmusa a tuberkul\u00f3zis kezel\u00e9s\u00e9t! - K\u00edna Vegyi Gy\u00e1rt\u00f3","isPartOf":{"@id":"https:\/\/longchangextracts.com\/#website"},"datePublished":"2024-04-16T08:28:19+00:00","dateModified":"2024-04-16T08:28:19+00:00","author":{"@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869"},"breadcrumb":{"@id":"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/#breadcrumb"},"inLanguage":"hu","potentialAction":[{"@type":"ReadAction","target":["https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/longchangextracts.com\/"},{"@type":"ListItem","position":2,"name":"How Protionamide’s Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment!"}]},{"@type":"WebSite","@id":"https:\/\/longchangextracts.com\/#website","url":"https:\/\/longchangextracts.com\/","name":"K\u00edna Vegyi Gy\u00e1rt\u00f3","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/longchangextracts.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"hu"},{"@type":"Person","@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869","name":"longcha9","image":{"@type":"ImageObject","inLanguage":"hu","@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g","caption":"longcha9"}}]}},"_links":{"self":[{"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/posts\/3390"}],"collection":[{"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/comments?post=3390"}],"version-history":[{"count":0,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/posts\/3390\/revisions"}],"wp:attachment":[{"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/media?parent=3390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/categories?post=3390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/tags?post=3390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}